| |
MK (ng/ml)
|
P value
|
TG (ng/ml)
|
P value
|
MK/TG (ng/mg)
|
P value
|
FT4(pmol/L)
|
P value
|
MK/FT4(μg/pmol)
|
P value
|
FT4/MK (pmol /μg)
|
P value
|
|---|
|
Number of nodules
| |
0.392
| |
0.431
| |
0.158
| |
0.449
| |
0.324
| |
0.324
|
|
Solitary
|
0.47 (0.02,16.93)
| |
5003.25 (155,230,050)
| |
96 (2.10,4021.67)
| |
3.8 (0.33,78.57)
| |
0.1 (0.002,6.84)
| |
9.57 (0.15,563.76)
| |
|
Multiple
|
0.39 (0.02,12.07)
| |
5711.25 (560,3,224,500)
| |
70.97 (1.52,1202.08)
| |
4.06 (0.48,141.3)
| |
0.07 (0.001,8.21)
| |
14.81 (0.12,910.94)
| |
|
aMTD
| |
0.000*
| |
0.691
| |
0.009*
| |
0.395
| |
0.001*
| |
0.001*
|
|
≤ 1 cm
|
0.27 (0.013,12.07)
| |
5711.29 (171,230,050)
| |
58.83 (1.52,4021.37)
| |
4.05 (0.54,96.95)
| |
0.06 (0.001,8.21)
| |
17.06 (0.12,910.94)
| |
|
>1 cm, ≤ 2 cm
|
0.56 (0.06,16.93)
| |
4119.5 (155,178,100)
| |
161.09 (3.56,2380.22)
| |
3.85 (0.33,80.69)
| |
0.32 (0.004,6.32)
| |
3.16 (0.16,222.71)
| |
|
>2 cm, ≤4 cm
|
2.50 ± 2.84
| |
8205 (199,3,224,500)
| |
389.81 ± 516.56
| |
2.29 (0.39,141.3)
| |
1.07 ± 1.47
| |
9.53 ± 16.76
| |
|
bETE
| |
0.241
| |
0.009*
| |
0.001*
| |
0.009*
| |
0.003*
| |
0.003*
|
|
No invasion
|
0.37 (0.015,16.93)
| |
9230 (1845,300,500)
| |
40.31 (0.31,1766.59)
| |
6.56 (0.39,332.9)
| |
0.05 (0.001,8.21)
| |
21.92 (0.12,708.99)
| |
|
cCapsule and the outside
|
0.55 (0.02,9.79)
| |
3457.25 (155,3,224,500)
| |
138.95 (2.37,4021.37)
| |
2.73 (0.33,141.3)
| |
0.21 (0.005,6.84)
| |
4.74 (0.15,222.71)
| |
|
dSoft tissues or strap muscles
|
0.35 (0.013,6.42)
| |
3479.75 (1117.519935)
| |
210.42 (3.99,861.67)
| |
5.2 (0.51,96.96)
| |
0.0096 (0.001,6.32)
| |
15.66 (0.16,910.94)
| |
|
T stage
| |
0.008*
| |
0.119
| |
0.002*
| |
0.269
| |
0.002*
| |
0.002*
|
|
T1a
|
0.27 (0.02,12.07)
| |
5807.5 (171,230,050)
| |
60.50 (1.52,4021.37)
| |
3.96 (0.54,89.70)
| |
0.06 (0.001,8.21)
| |
16.63 (0.12,708.99)
| |
|
T1b
|
0.61 (0.06,16.93)
| |
5003.25 (155,178,100)
| |
137.38 (3.56,2380.22)
| |
4.08 (0.33,80.69)
| |
0.31 (0.005,2.85)
| |
3.24 (0.35,222.71)
| |
|
T2
|
1.37 (0.30,8.05)
| |
8205 (199,3,224,500)
| |
196.78 (2.37,1766.59)
| |
2.29 (0.39,141.3)
| |
0.59 (0.02,5.00)
| |
1.68 (0.20,56.72)
| |
|
T3b
|
0.35 (0.11,3.22)
| |
3327.25 (1117.519935)
| |
210.42 (8.82,861.67)
| |
3.05 (0.51,96.96)
| |
0.10 (0.002,6.32)
| |
15.66 (0.16,551.37)
| |
|
T4a
|
3.22 (0.01,6.42)
| |
6490.5 (3255,9726)
| |
332.18 (3.99,660.37)
| |
9.29 (6.73,11.84)
| |
0.48 (0.001,0.95)
| |
455.99 (1.05,910.94)
| |
|
N stage
| |
0.006*
| |
0.635
| |
0.064
| |
0.587
| |
0.025*
| |
0.025*
|
|
N0
|
0.26 (0.02,9.79)
| |
4645.00 (171.00,230,050.00)
| |
46.35 (1.52,4021.37)
| |
4.53 (0.33,78.50)
| |
0.07 (0.001,6.84)
| |
15.16 (0.15,708.99)
| |
|
N1
|
0.52 (0.013,16.93)
| |
6162.50 (155.00,3,224,500.00)
| |
111.80 (2.37,2380.22)
| |
3.72 (0.39,141.30)
| |
0.13 (0.001,8.21)
| |
7.94 (0.12,910.94)
| |
- a MTD maximum tumor diameter, b ETE extrathyroidal extension, c capsule and the outside invasion through the capsule and reached the outside, d soft tissues or strap muscles perithyroidal soft tissues or strap muscles
- *P<0.05
